J. Anthony Child

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory et al. · The Lancet · 2010 · 566 citations · Full text

Hematological Malignancy, Zoledronic Acid, Oncology +8

Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation

Brian G.M. Durie, Robert A. Kyle, Andrew R. Belch et al. · The Hematology Journal · 2003 · 423 citations

International Myeloma Foundation, Hematological Malignancy, Oncology +7

A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial

Kevin Boyd, F. M. Ross, Laura Chiecchio et al. · Leukemia · 2011 · 344 citations · Full text

Hematological Malignancy, Novel Prognostic Model, Medicine +9

The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis

Gareth J. Morgan, Walter M. Gregory, Faith E. Davies et al. · Blood · 2011 · 329 citations

Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation

Andy C. Rawstron, Faith E. Davies, Ranjit Dasgupta et al. · Blood · 2002 · 209 citations